Botzenhardt U, Lemmel E M
Agents Actions. 1975 Dec;5(5):512-8. doi: 10.1007/BF01972688.
The kinetics of the reactive cell clones after primary and secondary immunization with SRBC1) modified by cyclophosphamide and a newly synthesized cyclophosphamide analogue 036.5122 (Asta), have been studied. After primary immunization, both substances caused a severe and dose dependent depletion of 19 S PFC2). The 7 S PFC in the late primary response were only slightly inhibited by cyclophosphamide in low dose ranges, indicating, that sensitization could not be prevented by this substance. In contrast, 0.36.5122 was fully able to suppress 7 S PFC. Thus, treatment with 0.36.5122 after primary immunization can fully prevent the expression of the specific response. Experiments dealing with inhibition of a secondary immune response revealed that both test substances were able to strongly suppress the 19 S as well as the 7 S PFC. In general, 036.5122 demonstrates a higher suppressive potency, and the timing of its application for optimal suppression is less delicate than that of cyclophosphamide. 036.5122 was equally well inhibitory, whether given directly before or after antigenic challenge. The hypothesis is discussed, whether the immunosuppressive effect of 036.5122 given before antigenic challenge in the secondary immune response is due to cytotoxic damage of antigen reactive clones stimulated by persisting antigen.
研究了用环磷酰胺和新合成的环磷酰胺类似物036.5122(阿斯塔)修饰的绵羊红细胞(SRBC)进行初次和二次免疫后反应性细胞克隆的动力学。初次免疫后,两种物质均引起19S浆细胞集落形成单位(PFC)严重且剂量依赖性的减少。在初次反应后期,低剂量范围内的环磷酰胺仅轻微抑制7S PFC,这表明该物质不能阻止致敏。相比之下,036.5122能够完全抑制7S PFC。因此,初次免疫后用036.5122处理可完全阻止特异性反应的表达。关于二次免疫反应抑制的实验表明,两种受试物质均能强烈抑制19S和7S PFC。一般来说,036.5122表现出更高的抑制效力,并且其用于最佳抑制的给药时间比环磷酰胺的要求不那么严格。无论在抗原攻击之前还是之后给予,036.5122的抑制效果均相同。讨论了在二次免疫反应中抗原攻击前给予036.5122的免疫抑制作用是否归因于持续抗原刺激的抗原反应性克隆的细胞毒性损伤这一假说。 1)SRBC:绵羊红细胞 2)19S PFC:19S浆细胞集落形成单位 7S PFC:7S浆细胞集落形成单位 036.5122:一种新合成的环磷酰胺类似物 Asta:阿斯塔 (注:以上括号内容为方便理解添加,原文无)